Naveen Bellam, MD
Advanced Heart Failure and Transplant Cardiology · Orlando, FLNPI 1619260239
Payments from drug & device makers
Across 580 payments — averaging $713.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$250K
- Merck$99K
- Bridgebio Pharma, Inc.$31K
- Impulse Dynamics (USA) Inc.$19K
- Pfizer$11K
- Abbott$1K
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 315 | $250,124 |
| Merck | 81 | $99,423 |
| Bridgebio Pharma, Inc. | 35 | $30,637 |
| Impulse Dynamics (USA) Inc. | 41 | $18,531 |
| Pfizer | 19 | $10,949 |
| Abbott | 29 | $1,219 |
| Cvrx, Inc. | 21 | $840 |
| Medtronic | 2 | $219 |
| Kestra Medical Technology Services, Inc. | 3 | $201 |
| Abiomed | 2 | $176 |
| Boston Scientific | 1 | $147 |
| Daxor Corporation | 2 | $145 |
| Akcea Therapeutics, Inc. | 1 | $138 |
| United Therapeutics Corporation | 1 | $134 |
| Nuwellis, Inc. | 1 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Novo Nordisk | 1 | $111 |
| Boehringer Ingelheim | 2 | $103 |
| American Regent | 2 | $98 |
| E.r. Squibb & Sons, L.L.C. | 5 | $96 |
| AstraZeneca | 1 | $53 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $52 |
| Cardiac Dimensions, Inc. | 2 | $52 |
| Scpharmaceuticals Inc. | 2 | $44 |
| Eurofins Viracor, LLC | 1 | $37 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $30 |
| Sanofi | 1 | $29 |
| Bayer | 1 | $27 |
| Briohealth Solutions, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $17 |
How this compares
$413,923 in reported general payments places this provider in the 85th percentile of 48 advanced heart failure and transplant cardiology providers in Florida.
See all advanced heart failure and transplant cardiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Orlando
- Stacy MandrasOrlando$959K
- Andrija VidicOrlando$449K
- Pujan PatelOrlando$66K
- Sula MazimbaOrlando$61K
- Mauricio VelezOrlando$39K
- Shahid QamarOrlando$38K
- Sushma KoneruOrlando$26K
- Jacqueline DoweOrlando$7K
- Akanksha AgrawalOrlando$5K
- Krithika KrishnaraoOrlando$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.